According to our report, the Pharmaceutical Filtration Market size in the Asia Pacific was valued at USD 3.62 billion in 2021. It is estimated to be growing at a CAGR of 11.3% and worth USD 6.18 billion by 2026.
The market is expected to expand at a fast rate during the forecast period. Filtration refers to the process of removal of suspended particles from a medium by passing them through a membrane. It is a widely used physical technique for separation employed by various industries. It can be combined with other techniques like sieving. However, it uses a multi-layer lattice, whereas sieving uses a single perforated layer.
The pharmaceutical filtration market in the Asia Pacific is projected to expand at a rapid pace, led by the rise in healthcare expenditure, increase in government initiatives and funding, high prevalence of diseases such as rabies, polio, and malaria in various countries in the region, and growth in investment by major market players in emerging economies. However, large capital requirements and strict validation and qualification procedures in different countries are expected to hamper the market during the forecast period.
This research report on the Asia Pacific Pharmaceutical Filtration Market has been segmented and sub-segmented into the following categories:
By Product:
By Technique:
By Application:
By Country:
Companies playing a dominant role in the APAC Pharmaceutical Filtration Market Profiled in the Report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Membrane filters
5.1.2.1 MCE Membrane Filters
5.1.2.2 Coated Cellulose Acetate Membrane Filters
5.1.2.3 PTFE Membrane Filters
5.1.2.4 Nylon Membrane Filters
5.1.2.5 PVDF Membrane Filters
5.1.2.6 Other Membrane Filters
5.1.3 Prefilters and depth media filters
5.1.3.1 Glass fibre filters
5.1.3.2 PTFE fibre filters
5.1.4 Single use systems
5.1.5 Cartridge and capsule filters
5.1.6 Filter holders
5.1.7 Filtration accessories
5.1.8 Other products
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By product
5.1.11 Market Share Analysis, By Product
5.2 Technique
5.2.1 Introduction
5.2.2 Microfiltration
5.2.3 Ultrafiltration
5.2.4 Nano filtration
5.2.5 Other techniques
5.2.6 Y-o-Y Growth Analysis, By Technique
5.2.7 Market Attractiveness Analysis, By Technique
5.2.8 Market Share Analysis, By Technique
5.3 Application
5.3.1 Introduction
5.3.2 Final product processing
5.3.2.1 API filtration
5.3.2.2 Sterile filtration
5.3.2.3 Protein purification
5.3.2.4 Vaccine and antibody processing
5.3.2.5 Formulation and Filling Solution Filtration
5.3.2.6 Viral Clearance
5.3.3 Raw material filtration
5.3.3.1 Media and buffer filtration
5.3.3.2 Prefiltration
5.3.3.3 Bioburden testing
5.3.4 Cell seperation
5.3.5 Water purification
5.3.6 Air purification
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 Scale of operation
5.4.1 Introduction
5.4.2 Manufacturing scale
5.4.3 Pilot scale
5.4.4 R&D scale
5.4.5 Y-o-Y Growth Analysis, By Scale of Operation
5.4.6 Market Attractiveness Analysis, By Scale of Operation
5.4.7 Market Share Analysis, By Scale of Operation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.3.5 By Scale of operation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.4.5 By Scale of operation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.1.5.5 By Scale of operation
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Pall Corporation
8.4 3M Company
8.5 Parker Hannifin Corporation
8.6 Sartorius Stedim Biotech S.A.
8.7 Eaton Corporation PLC
8.8 Amazon Filters Ltd.
8.9 Meissner Filtration Products, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
